All updated as on -
From 2024–2031, the worldwide contrast media industry is projected to expand from an initial valuation of $6.33B at a CAGR (compound annual growth rate) of 9.98%.
Diagnostic imaging procedures including X-rays, ultrasound, and more modern imaging technologies like MRI and CT scans have increased in popularity due to the rising incidence of complicated comorbidities and chronic diseases. For patients two years of age and older, the United States Food and Drug Administration (FDA) authorized Gadopiclenol in September 2023 as an MRI contrast agent that has a lower gadolinium dosage and high relativity. Gadopiclenol is a macrocyclic GBCA that aids in the detection of abnormal vascularity in several organs and tissues, including the brain, spine, and abdomen. In 2023, about 45 percent of Americans were impacted by various chronic illnesses, according to the National Association of Chronic Disease Directors.
In order to understand the patient's health status, contrast agents are chemical components that are injected into their body prior to imaging the test. The increasing incidence of complex co-morbidities nic diseases is driving the need for diagnostic imaging procedures, including ultrasonography, X-rays, and state-of-the-art imaging equipment like magnetic resonance imaging (MRI) and computed tomography (CT) scans. The US Food and Drug Administration put the contrast agent Claris can to use in macrocyclic magnetic resonance imaging (MRI). Products like these are anticipated to drive market expansion since they help doctors decide whether preoperative scans are necessary before operations and therapy in interventional procedures.
The main factors driving the market's rise are the increasing number of diagnostic procedures and the demand for treatments that are less invasive. It is critical to possess an in-depth knowledge of imaging and its therapeutic applications in order to meet the rising need for high-quality surgical imaging. Consequently, fresh approaches to data collection, processing, and display are necessary. The increasing need for diagnosis and treatment on a global scale has been superbly met by image-guided therapy in recent years. The outcome is a higher contrast media market CAGR.
X-rays and CAT scans often make use of contrast chemicals based on iodine to improve the clarity of the images. They make the digestive system, the brain, and other internal organs easier to see. Many different types of medical conditions, including those affecting the nervous system, kidneys, gastrointestinal tract, heart, muscles, and cancer, can be alleviated with the use of iodinated contrast agents. The result is a dramatic increase in the demand for media that boosts contrast.
The number of cancer patients has risen sharply during the past few decades. People are becoming less active and eating a lot of calories from fat, processed carbs, and animal protein. This trend is happening in many countries around the world. The prevalence of cancer is projected to rise in tandem with these alterations in lifestyle. Diagnostic imaging treatments make use of contrast media to improve the visibility of anatomical structures and organs. The market for contrast media will be driven by the increasing demand for sophisticated diagnostic imaging procedures, which in turn will be driven by the rising prevalence of chronic diseases including cancer and CVD.
In most cases, using contrast agents in diagnostic procedures like MRI and CT scans is not associated with any negative health effects. Their use is connected with a number of potential adverse effects including allergic responses, which could slow market expansion. Their negative reactions can be modest to severe; nevertheless, severe reactions are extremely unusual, and severe allergies to contrast materials are even more rare.
There is a record-high need for diagnostic imaging due to the prevalence of chronic diseases of various forms. According to a report from the Medicare Payment Advisory Council (MedPAC) to the Centers for Medicare and Medicaid Services (CMS), the number of imaging services per Medicare beneficiary increased at the greatest rate compared to all other physician services.
More and more people are warming up to the idea of image-guided surgery (IGS). These procedures can be helpful for a wide range of medical diagnoses and treatments. A thorough familiarity with imaging and its therapeutic applications is necessary to meet the increasing need for image enhancement during surgery, which in turn necessitates novel approaches to data gathering, processing, and display. The rise in demand for diagnosis and treatment, fueled by image-guided treatments, has contributed to the acceleration of the contrast media market CAGR worldwide in recent years.
Report Coverage
Global Contrast Media research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Contrast Media report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Contrast Media competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Contrast Media market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Contrast Media market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Contrast Media market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.)
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Contrast Media market based on the below-mentioned segments:
Global Contrast Media Market, By Type
Iodinated Contrast Media
Gadolinium-Based Contrast Media
Global Contrast Media market, By Application
Cardiovascular Disease
Oncology
Gastrointestinal Disorders
Global Contrast Media Market, By Form
Tablet
Powder
Liquid
Paste
Global Contrast Media market, Regional Analysis
Diagnostic imaging procedures including X-rays, ultrasound, and more modern imaging technologies like MRI and CT scans have increased in popularity due to the rising incidence of complicated comorbidities and chronic diseases. For patients two years of age and older, the United States Food and Drug Administration (FDA) authorized Gadopiclenol in September 2023 as an MRI contrast agent that has a lower gadolinium dosage and high relativity. Gadopiclenol is a macrocyclic GBCA that aids in the detection of abnormal vascularity in several organs and tissues, including the brain, spine, and abdomen. In 2023, about 45 percent of Americans were impacted by various chronic illnesses, according to the National Association of Chronic Disease Directors.
In order to understand the patient's health status, contrast agents are chemical components that are injected into their body prior to imaging the test. The increasing incidence of complex co-morbidities nic diseases is driving the need for diagnostic imaging procedures, including ultrasonography, X-rays, and state-of-the-art imaging equipment like magnetic resonance imaging (MRI) and computed tomography (CT) scans. The US Food and Drug Administration put the contrast agent Claris can to use in macrocyclic magnetic resonance imaging (MRI). Products like these are anticipated to drive market expansion since they help doctors decide whether preoperative scans are necessary before operations and therapy in interventional procedures.
The main factors driving the market's rise are the increasing number of diagnostic procedures and the demand for treatments that are less invasive. It is critical to possess an in-depth knowledge of imaging and its therapeutic applications in order to meet the rising need for high-quality surgical imaging. Consequently, fresh approaches to data collection, processing, and display are necessary. The increasing need for diagnosis and treatment on a global scale has been superbly met by image-guided therapy in recent years. The outcome is a higher contrast media market CAGR.
X-rays and CAT scans often make use of contrast chemicals based on iodine to improve the clarity of the images. They make the digestive system, the brain, and other internal organs easier to see. Many different types of medical conditions, including those affecting the nervous system, kidneys, gastrointestinal tract, heart, muscles, and cancer, can be alleviated with the use of iodinated contrast agents. The result is a dramatic increase in the demand for media that boosts contrast.
The number of cancer patients has risen sharply during the past few decades. People are becoming less active and eating a lot of calories from fat, processed carbs, and animal protein. This trend is happening in many countries around the world. The prevalence of cancer is projected to rise in tandem with these alterations in lifestyle. Diagnostic imaging treatments make use of contrast media to improve the visibility of anatomical structures and organs. The market for contrast media will be driven by the increasing demand for sophisticated diagnostic imaging procedures, which in turn will be driven by the rising prevalence of chronic diseases including cancer and CVD.
In most cases, using contrast agents in diagnostic procedures like MRI and CT scans is not associated with any negative health effects. Their use is connected with a number of potential adverse effects including allergic responses, which could slow market expansion. Their negative reactions can be modest to severe; nevertheless, severe reactions are extremely unusual, and severe allergies to contrast materials are even more rare.
There is a record-high need for diagnostic imaging due to the prevalence of chronic diseases of various forms. According to a report from the Medicare Payment Advisory Council (MedPAC) to the Centers for Medicare and Medicaid Services (CMS), the number of imaging services per Medicare beneficiary increased at the greatest rate compared to all other physician services.
More and more people are warming up to the idea of image-guided surgery (IGS). These procedures can be helpful for a wide range of medical diagnoses and treatments. A thorough familiarity with imaging and its therapeutic applications is necessary to meet the increasing need for image enhancement during surgery, which in turn necessitates novel approaches to data gathering, processing, and display. The rise in demand for diagnosis and treatment, fueled by image-guided treatments, has contributed to the acceleration of the contrast media market CAGR worldwide in recent years.
Report Coverage
Global Contrast Media research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Contrast Media report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Contrast Media competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Contrast Media market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.) |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Contrast Media Market from 2021 to 2031.
- Market Forecast for Contrast Media Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Contrast Media competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Contrast Media
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Contrast Media market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Contrast Media market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.)
Primary Target Market
- Market Players of Contrast Media
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Contrast Media market based on the below-mentioned segments:
Global Contrast Media Market, By Type
Iodinated Contrast Media
Gadolinium-Based Contrast Media
Global Contrast Media market, By Application
Cardiovascular Disease
Oncology
Gastrointestinal Disorders
Global Contrast Media Market, By Form
Tablet
Powder
Liquid
Paste
Global Contrast Media market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive contrast media market market research and competitor analysis for your business to help you develop more profound insights into the contrast media market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the contrast media market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.